A carregar...
Efficacy and Safety of Sucroferric Oxyhydroxide and Calcium Carbonate in Hemodialysis Patients
INTRODUCTION: In this phase III, open-label, single-arm, multi-center 12-week study, we evaluated the efficacy and safety of combination therapy with sucroferric oxyhydroxide (PA21) and calcium carbonate for hemodialysis patients with hyperphosphatemia. METHODS: We enrolled 35 subjects aged ≥ 20 yea...
Na minha lista:
| Publicado no: | Kidney Int Rep |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5762971/ https://ncbi.nlm.nih.gov/pubmed/29340330 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ekir.2017.10.003 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|